Drug
Encorafenib Cetuximab
Encorafenib Cetuximab: highest development phase Phase 2, developed by Pierre Fabre. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Pierre Fabre
Trials
| Drug | Phase | Indication |
|---|---|---|
| Encorafenib Oral Capsule + Cetuximab NCT05706779 | Phase 2 | Colorectal Cancer |
Latest
No recent events.
Follow Encorafenib Cetuximab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.